develop a PICOT question addressing a significant clinical challenge in your area of practice. The project should reflect the application of EBP principles throughout the process. You will identify a clinical problem, develop a PICOT question and conduct a literature review.
Problem Identification and Literature Review: Clearly identify a significant clinical problem within your area of expertise, justifying its selection based on evidence of a practice gap and its potential for improvement through EBP. Conduct a thorough literature review to support your choice and inform the development of your intervention. (Minimum of 5 peer-reviewed sources).
PICOT: Based on the literature review, design a PICOT question to address the chosen problem. Provide rationales for each part of your PICOT question.
Barriers and Theory Application: Identify 2-3 barriers that may exist for implementing your intervention. Using nursing theory, describe how you would overcome those barriers.
as a healthcare professional practicing in Kenya, a significant clinical challenge I’ve observed is the suboptimal adherence to antiretroviral therapy (ART) among adolescents living with HIV (ALHIV). This is a critical issue as poor adherence leads to virological failure, increased risk of opportunistic infections, drug resistance, and ultimately impacts their long-term health outcomes and quality of life. There’s a clear practice gap as evidenced by studies showing lower adherence rates in adolescents compared to adults in Kenya (e.g., studies published in the East African Medical Journal or AIDS Care focusing on the region). Improving ART adherence in this population is a key area where evidence-based practice can make a substantial difference.
Problem Identification and Literature Review:
My choice of suboptimal ART adherence in ALHIV is supported by several factors identified in the literature:
- Developmental Stage: Adolescence is a period of significant physical, emotional, and social changes. Issues such as body image concerns, peer influence, rebellion against authority, and developing autonomy can interfere with consistent medication taking ( подростковый возраст).
- Psychosocial Factors: Stigma associated with HIV, disclosure challenges, mental health issues (depression, anxiety), lack of social support, and unstable living situations are significant barriers to adherence in ALHIV (психосоциальные факторы).
- Treatment Fatigue and Pill Burden: The need for lifelong daily medication can lead to treatment fatigue, especially as adolescents navigate their daily lives, school, and social activities (усталость от лечения).
- Knowledge Gaps and Misconceptions: Some ALHIV may have limited understanding of the importance of consistent adherence or harbor misconceptions about their medication (пробелы в знаниях).
- Access and System-Level Barriers: While access to ART has improved in Kenya, issues like clinic distance, transportation costs, medication stockouts at local facilities, and unfriendly healthcare worker attitudes can still pose challenges (барьеры доступа).
Literature Review (Simulated – based on likely findings in peer-reviewed journals focusing on HIV in sub-Saharan Africa and adolescent health):
- Kimberlin, D. W., Brady, M. T., Jackson, M. A., & Long, S. S. (Eds.). (2018). Red Book: 2018-2021 Report of the Committee on Infectious Diseases (31st ed.). American Academy of Pediatrics. 1 (While a US-based resource, it highlights general challenges of medication adherence in adolescents with chronic conditions).
1. www.yhoclamsang.net
- Nachega, J. B., Mugavero, M. J., Giordano, T. P., Fleishman, J. A., Bartlett, J. A., & The Antiretroviral Therapy Adherence Working Group. (2010). Antiretroviral therapy adherence: what we have learned in 25 years of the HIV epidemic and what we need to know. Clinical Infectious Diseases, 50(Suppl 3), S254-S260. (Provides a broader overview of ART adherence challenges, relevant to the context of lifelong treatment).
as a healthcare professional practicing in Kenya, a significant clinical challenge I’ve observed is the suboptimal adherence to antiretroviral therapy (ART) among adolescents living with HIV (ALHIV). This is a critical issue as poor adherence leads to virological failure, increased risk of opportunistic infections, drug resistance, and ultimately impacts their long-term health outcomes and quality of life. There’s a clear practice gap as evidenced by studies showing lower adherence rates in adolescents compared to adults in Kenya (e.g., studies published in the East African Medical Journal or AIDS Care focusing on the region). Improving ART adherence in this population is a key area where evidence-based practice can make a substantial difference.
Problem Identification and Literature Review:
My choice of suboptimal ART adherence in ALHIV is supported by several factors identified in the literature:
- Developmental Stage: Adolescence is a period of significant physical, emotional, and social changes. Issues such as body image concerns, peer influence, rebellion against authority, and developing autonomy can interfere with consistent medication taking ( подростковый возраст).
- Psychosocial Factors: Stigma associated with HIV, disclosure challenges, mental health issues (depression, anxiety), lack of social support, and unstable living situations are significant barriers to adherence in ALHIV (психосоциальные факторы).
- Treatment Fatigue and Pill Burden: The need for lifelong daily medication can lead to treatment fatigue, especially as adolescents navigate their daily lives, school, and social activities (усталость от лечения).
- Knowledge Gaps and Misconceptions: Some ALHIV may have limited understanding of the importance of consistent adherence or harbor misconceptions about their medication (пробелы в знаниях).
- Access and System-Level Barriers: While access to ART has improved in Kenya, issues like clinic distance, transportation costs, medication stockouts at local facilities, and unfriendly healthcare worker attitudes can still pose challenges (барьеры доступа).
Literature Review (Simulated – based on likely findings in peer-reviewed journals focusing on HIV in sub-Saharan Africa and adolescent health):
- Kimberlin, D. W., Brady, M. T., Jackson, M. A., & Long, S. S. (Eds.). (2018). Red Book: 2018-2021 Report of the Committee on Infectious Diseases (31st ed.). American Academy of Pediatrics. 1 (While a US-based resource, it highlights general challenges of medication adherence in adolescents with chronic conditions).
1. www.yhoclamsang.net
- Nachega, J. B., Mugavero, M. J., Giordano, T. P., Fleishman, J. A., Bartlett, J. A., & The Antiretroviral Therapy Adherence Working Group. (2010). Antiretroviral therapy adherence: what we have learned in 25 years of the HIV epidemic and what we need to know. Clinical Infectious Diseases, 50(Suppl 3), S254-S260. (Provides a broader overview of ART adherence challenges, relevant to the context of lifelong treatment).